E-DRUG: Grant Announcement from the Stop TB Partnership
-----------------------------------------------
Stop TB is a network of partners working together to eliminate tuberculosis as a public health problem.
We encourage you to forward this announcement to friends or colleagues who you feel might be interested in the content below.
--
Call for proposals -- the International Union Against Tuberculosis & Lung Disease funding opportunity
8 June 2005 Paris
The International Union Against Tuberculosis & Lung Disease now calls for proposals for fidelis, a grant programme to support innovative tuberculosis control activities.
fidelis funds projects that will improve the detection and successful treatment of new sputum smear positive (NSP) tuberculosis patients, especially among people with limited access to health services.
fidelis are particularly interested in receiving high quality proposals with:
a) a lower cost per weighted treatment success;
b) a larger number of additional cases cured;
c) clear evidence of complementarity to existing health services and TB control efforts and for which the probability of sustainability within the existing system is judged to be highest;
d) the highest numbers of additional treatment success among people with limited access to health services;
e) convincing evidence that the innovations developed will be taken up into routine practice within the community.
The grant size ranges from US$ 150,000 to US$ 250,000. The deadline for receipt of applications is 1 August 2005.
For more information, please visit the web site:
http://www.fidelistb.org/
For further assistance contact:
Prof. Donald Enarson, Coordinator of fidelis
International Union Against Tuberculosis and Lung Disease (The Union)
68, boulevard Saint-Michel, 75006 Paris, France
Fax No. +33-1-5680-2820
mailto:enquiries@fidelistb.org